1
|
Berger R, Lescan M, Andic M, Schlensak C, Mustafi M. Use of Custom-Made and Parallel Endografts with Debranching Procedures for the Treatment of Pseudoaneurysms after Coarctation Surgery. Thorac Cardiovasc Surg 2023. [DOI: 10.1055/s-0043-1761642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2023]
Affiliation(s)
- R. Berger
- Department of Thoracic and Cardiovascular Surgery, Tübingen, Deutschland
| | - M. Lescan
- Department of Thoracic and Cardiovascular Surgery, Tübingen, Deutschland
| | - M. Andic
- Department of Thoracic and Cardiovascular Surgery, Tübingen, Deutschland
| | - C. Schlensak
- Department of Thoracic and Cardiovascular Surgery, Tübingen, Deutschland
| | - M. Mustafi
- Department of Thoracic and Cardiovascular Surgery, Tübingen, Deutschland
| |
Collapse
|
2
|
Abstract
BACKGROUND AND AIMS Timely access to approved medications is a priority in paediatric inflammatory bowel disease [IBD]. To date, the timing of drug studies in paediatric IBD has been suboptimal, with most studies conducted long after approval has been granted for adult IBD. This delay in approval leads to extensive off-label prescribing of medications in children, often without clear guidance on optimal dosing. The European Medicines Agency [EMA] and U.S. Food and Drug Administration [FDA] have implemented drug development frameworks in an attempt to address these challenges. However, access to information on these regulatory pathways in paediatric IBD is limited. We summarised the time from adult to paediatric approval of IBD therapies, outlining the regulatory approval pathway between the EMA and FDA, with the goal of identifying areas for improvement. METHODS We reviewed publicly accessible data from the EMA and the FDA to identify therapeutic agents approved over 2005-2021 for paediatric IBD. RESULTS AND CONCLUSIONS Five drugs are currently approved for use in the paediatric IBD population, with long interval delays after adult approval. The impact of these drug development processes in paediatric IBD is awaited. Further consideration needs to be given to the age of enrolment along with novel, more efficient trial designs in an effort to improve access for paediatric IBD patients to newer therapies.
Collapse
Affiliation(s)
- Eileen Crowley
- Department of Pediatrics, Division of Pediatric Gastroenterology & Hepatology, Children's Hospital Western Ontario, Western University, London, ON, Canada.,Alimentiv Inc. [formerly Robarts Clinical Trials, Inc.], London, ON, Canada
| | - Christopher Ma
- Alimentiv Inc. [formerly Robarts Clinical Trials, Inc.], London, ON, Canada.,Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.,Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
| | - Marija Andic
- Alimentiv Inc. [formerly Robarts Clinical Trials, Inc.], London, ON, Canada
| | - Brian G Feagan
- Alimentiv Inc. [formerly Robarts Clinical Trials, Inc.], London, ON, Canada.,Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.,Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada
| | - Anne M Griffiths
- Division of Gastroenterology, Hepatology & Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada
| | - Vipul Jairath
- Alimentiv Inc. [formerly Robarts Clinical Trials, Inc.], London, ON, Canada.,Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.,Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada
| |
Collapse
|
3
|
Lescan M, Czerny M, Berezowski M, Andic M, Bamberg F, Beyersdorf F, Schlensak C, Rylski B. Morphological Performance Analysis of a “Nonbare Stent” Stent Graft in Dissected Thoracic Aorta. Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- M. Lescan
- Department of Thoracic and Cardiovascular Surgery, University Medical Center Tübingen, Tübingen, Germany
| | - M. Czerny
- Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany
| | - M. Berezowski
- Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany
| | - M. Andic
- Department of Thoracic and Cardiovascular Surgery, University Medical Center Tübingen, Tübingen, Germany
| | - F. Bamberg
- Department of Radiology, University Medical Center Tübingen, Tübingen, Germany
| | - F. Beyersdorf
- Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany
| | - C. Schlensak
- Department of Thoracic and Cardiovascular Surgery, University Medical Center Tübingen, Tübingen, Germany
| | - B. Rylski
- Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany
| |
Collapse
|